Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
about
Drug Metabolism - From In Vitro to In Vivo, From Simple to Complex: Reflections of the BCPT Nordic Prize 2014 AwardeeThe genetics of tobacco use: methods, findings and policy implicationsPolymorphisms of CYP2A6 and its practical consequencesFrequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.The genetics of nicotine dependence: relationship to pancreatic cancer.Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4.Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.Associations of CYP2A6 genotype with smoking behaviors in southern China.Applying genetic approaches to the treatment of nicotine dependence.Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.Pharmacogenetics of the major polymorphic metabolizing enzymes.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.Risk factors for tobacco dependence in adolescent smokers.CYP2A6 polymorphisms and risk for tobacco-related cancers.Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolismAssociation between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms.Effects of whole deletion of CYP2A6 on nicotine metabolism in humans.Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations.Variation in CYP2A6 Activity and Personalized Medicine.Gene, ethnic and gender influences predisposition of adverse drug reactions to artesunate among Malaysians.Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers.Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.Racially classified social group tobacco-related health disparities: what is the role of genetics?Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.CYP2A6 polymorphisms in Malays, Chinese and Indians.
P2860
Q28083049-9C5FBAD9-B72C-46DD-98D5-F97C89D44C64Q28201220-711D1FC1-5CED-4308-922B-B8481CA37467Q28362536-A2B0164C-B663-4BF8-93ED-DD77ABA1863EQ32160224-E7E5A8F0-913B-4E0C-B423-5BD80F973959Q33866866-6D75B214-61A4-4E89-8182-0BFB51DF2B80Q34180033-7E30C90B-BA33-40A4-BA0D-F8377E77CA0BQ34188511-B11CC3F8-730A-4E68-A9BB-C287ADD0852BQ34778875-B024B89A-7BEB-4CD8-8E33-DFA91ACB8F32Q34963561-7AC718E7-DF2B-4E48-87F5-5CACF7C07FE0Q35027945-DCDB50FC-AD69-4B6F-A8F8-F5161E516BA8Q35067187-E8F4A95C-6C3F-4DF7-835D-414ECC67F099Q35876954-E06FC22F-B0B6-4284-9BD2-866E5EAECB4FQ36203479-9CD17A9E-B80D-4CB3-A417-D068DFF16CAAQ36930336-168C8CF3-646B-47DA-BC0C-BD6C432DBBF1Q37329175-D382EDED-5527-4304-8DC6-FE8606B1059BQ37698407-DE1A0D02-66A2-4732-9ABA-B62A5A14A8D1Q37964573-2D04091C-FA77-4C50-BA1A-631C3B443828Q38683483-128214EC-5C2E-4F2E-8610-5AA80777142BQ40701329-8DE9375E-3350-4CAB-8C28-C0426E54F875Q40741413-5DEBDFF6-6E55-4B1F-BD80-22E067B040BBQ41927477-2F78DBB2-59D6-4B3D-81F3-D7AB0DB64F6BQ42284318-B56606CB-A31C-4473-8D5D-7F17EFFBE4E6Q43580817-B0018903-E967-4285-8EC7-5EFE0F9D0179Q43601299-C679800D-7A41-4337-A5E6-F8C8056A3466Q44002892-9515FED1-A980-4B72-94E6-60A58F1A0682Q44432242-5EE9BBF1-558F-4353-A6A6-674EAFA32FB9Q46436451-6F813CA9-5F82-48EB-8ADF-90E0F8B562E4Q47163198-BFEFE323-2A0B-403B-950B-EF8898D11FA3Q47575351-6BB9E56A-6E9E-4D29-9387-261B268F8C1EQ51370536-E487E972-A822-4EA7-B10F-AC760340A2CFQ52277603-544A0131-332C-47E1-998E-276914924618Q52291837-A0CBAA67-BFB3-47E4-9544-15A98814702FQ53686438-6A8720E5-6400-40FA-941C-ED6D4FEEE99DQ54588559-BBE317AE-6DCE-4DDF-9A6D-AC2879DADBC0
P2860
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@ast
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@en
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@nl
type
label
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@ast
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@en
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@nl
prefLabel
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@ast
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@en
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@nl
P2093
P2860
P1433
P1476
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase
@en
P2093
H Gullstén
J H Stengård
M Ingelman-Sundberg
M L Bernal
M Oscarson
O Pelkonen
P2860
P356
10.1016/S0014-5793(98)01297-6
P407
P577
1998-11-06T00:00:00Z